Biosynthesis and Metabolism of L-Glutathione

L-Glutathione is an organic tripeptide synthesized from the amino acids glutamate, cysteine, and glycine, characterized by a gamma‑peptide bond between the carboxyl group of the glutamate side‑chain and cysteine, while the cysteine residue is connected to glycine through a standard peptide linkage. L-Glutathione functions as a vital antioxidant across plants, animals, fungi, and certain bacteria and archaea, where it effectively shields essential cellular structures from oxidative and chemical damage induced by reactive oxygen species, free radicals, peroxides, lipid peroxides, and heavy metals.

Figure1: Picture of L-Glutathione

Overview

L-Glutathione is a widely distributed thiol‑containing tripeptide that holds a central position in cellular physiology. It orchestrates cellular adaptation to redox fluctuations driven by reactive oxygen species, facilitates the detoxification of drug metabolites, participates in the regulation of gene expression and apoptosis, and contributes to the transmembrane transport of organic solutes. Polymorphisms in key enzymes of L-Glutathione metabolism have been identified, and certain allelic variants are linked to compromised redox‑buffering capacity, downstream pathological states, and increased susceptibility to ischemic injury. These multifaceted functions render L-Glutathione a compelling focus for targeted, mechanism‑based strategies aimed at the prevention and management of numerous surgical‑relevant disorders. Low molecular weight sulfur‑containing compounds (thiols), including thioredoxin and reduced L-Glutathione, are readily oxidized and can be rapidly regenerated, properties that enable them to fulfill critical roles in a wide range of biochemical and pharmacological processes. The diverse functions of L-Glutathione may be categorized into three principal groups: (i) acting as a primary intracellular antioxidant, often in conjunction with superoxide dismutase; (ii) modulating cell proliferation and immune responses; and (iii) aiding in the regulation of intracellular signal transduction via molecules such as nuclear factor‑kappaB and protein tyrosine phosphatase 1‑B. These multifaceted activities influence numerous pathological conditions that are of direct relevance to surgical practice. [1]

Biosynthesis

The biosynthesis of L-Glutathione proceeds through two sequential adenosine triphosphate (ATP)-dependent enzymatic steps. Initially, γ‑glutamylcysteine is formed from L‑glutamate and L‑cysteine via the action of glutamate–cysteine ligase (also known as glutamate‑cysteine synthase), which constitutes the rate‑limiting step in the pathway. Subsequently, glycine is attached to the C‑terminus of γ‑glutamylcysteine in a reaction catalyzed by L-Glutathione synthetase. Although all animal cells possess the capacity to synthesize L-Glutathione, hepatic production is indispensable, as evidenced by the lethality observed in glutamate–cysteine ligase catalytic subunit (GCLC) knockout mice, which succumb within one month after birth due to the lack of liver L-Glutathione synthesis. Furthermore, the presence of an unusual gamma‑amide linkage within the L-Glutathione molecule confers resistance to hydrolysis by common cellular peptidases. [2]

Metabolism

In the context of its diverse metabolic roles, L-Glutathione is essential for the biosynthesis of leukotrienes and prostaglandins, contributes to cysteine storage, and augments the function of citrulline within the nitric oxide cycle. Additionally, it serves as a cofactor for L-Glutathione peroxidase and participates in hydrogen sulfide metabolism through the formation of S‑sulfanylL-Glutathione. [3]

In degradation of drug delivery systems

In several cancer types, such as lung, larynx, oral, and breast carcinomas, L-Glutathione concentrations are markedly elevated (10–40 mM) relative to healthy cells. This redox disparity makes drug‑delivery systems incorporating disulfide bonds—notably cross‑linked micro‑ or nanogels—particularly effective, as they undergo selective degradation in the presence of high intracellular levels of L-Glutathione. Following endocytic uptake, the nanogels encounter a reducing cytosolic environment rich in GSH, which acts as a potent electron donor. Through a thiol‑disulfide exchange reaction, GSH reduces the disulfide cross‑links, cleaving them into free thiols and thereby triggering the controlled release of the encapsulated therapeutic payload directly within the cancerous or tumor tissue. This mechanism capitalizes on the sharp redox gradient between the oxidizing extracellular space and the reducing intracellular milieu to achieve targeted drug delivery. [4]

Reference

[1] Noctor G, Queval G, Mhamdi A, et al. L-Glutathione[J]. The Arabidopsis Book/American Society of Plant Biologists, 2011, 9: e0142.

[2] White CC. Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Analytical Biochemistry. 318, 2: 175–180.

[3] Melideo S L, Jackson M R, Jorns M S. Biosynthesis of a central intermediate in hydrogen sulfide metabolism by a novel human sulfurtransferase and its yeast ortholog[J]. Biochemistry, 2014, 53(28): 4739-4753.

[4] Li Y, Maciel D, Rodrigues J, et al. Biodegradable polymer nanogels for drug/nucleic acid delivery[J]. Chemical reviews, 2015, 115(16): 8564-8608.

You may like